Cargando…
Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS
Emergence of extensively drug resistant tuberculosis (XDR-TB) is the consequence of the failure of second line TB treatment. Aminoglycosides are the important second line anti-TB drugs used to treat the multi drug resistant tuberculosis (MDR-TB). Main known mechanism of action of aminoglycosides is...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108770/ https://www.ncbi.nlm.nih.gov/pubmed/27895634 http://dx.doi.org/10.3389/fmicb.2016.01816 |
_version_ | 1782467416010260480 |
---|---|
author | Sharma, Divakar Lata, Manju Singh, Rananjay Deo, Nirmala Venkatesan, Krishnamurthy Bisht, Deepa |
author_facet | Sharma, Divakar Lata, Manju Singh, Rananjay Deo, Nirmala Venkatesan, Krishnamurthy Bisht, Deepa |
author_sort | Sharma, Divakar |
collection | PubMed |
description | Emergence of extensively drug resistant tuberculosis (XDR-TB) is the consequence of the failure of second line TB treatment. Aminoglycosides are the important second line anti-TB drugs used to treat the multi drug resistant tuberculosis (MDR-TB). Main known mechanism of action of aminoglycosides is to inhibit the protein synthesis by inhibiting the normal functioning of ribosome. Primary target of aminoglycosides are the ribosomal RNA and its associated proteins. Various mechanisms have been proposed for aminoglycosides resistance but still some are unsolved. As proteins are involved in most of the biological processes, these act as a potential diagnostic markers and drug targets. In the present study we analyzed the purely cytosolic proteome of amikacin (AK) and kanamycin (KM) resistant Mycobacterium tuberculosis isolates by proteomic and bioinformatic approaches. Twenty protein spots were found to have over expressed in resistant isolates and were identified. Among these Rv3208A, Rv2623, Rv1360, Rv2140c, Rv1636, and Rv2185c are six proteins with unknown functions or undefined role. Docking results showed that AK and KM binds to the conserved domain (DUF, USP-A, Luciferase, PEBP and Polyketidecyclase/dehydrase domain) of these hypothetical proteins and over expression of these proteins might neutralize/modulate the effect of drug molecules. TBPred and GPS-PUP predicted cytoplasmic nature and potential pupylation sites within these identified proteins, respectively. String analysis also suggested that over expressed proteins along with their interactive partners might be involved in aminoglycosides resistance. Cumulative effect of these over expressed proteins could be involved in AK and KM resistance by mitigating the toxicity, repression of drug target and neutralizing affect. These findings need further exploitation for the expansion of newer therapeutics or diagnostic markers against AK and KM resistance so that an extreme condition like XDR-TB can be prevented. |
format | Online Article Text |
id | pubmed-5108770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51087702016-11-28 Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS Sharma, Divakar Lata, Manju Singh, Rananjay Deo, Nirmala Venkatesan, Krishnamurthy Bisht, Deepa Front Microbiol Microbiology Emergence of extensively drug resistant tuberculosis (XDR-TB) is the consequence of the failure of second line TB treatment. Aminoglycosides are the important second line anti-TB drugs used to treat the multi drug resistant tuberculosis (MDR-TB). Main known mechanism of action of aminoglycosides is to inhibit the protein synthesis by inhibiting the normal functioning of ribosome. Primary target of aminoglycosides are the ribosomal RNA and its associated proteins. Various mechanisms have been proposed for aminoglycosides resistance but still some are unsolved. As proteins are involved in most of the biological processes, these act as a potential diagnostic markers and drug targets. In the present study we analyzed the purely cytosolic proteome of amikacin (AK) and kanamycin (KM) resistant Mycobacterium tuberculosis isolates by proteomic and bioinformatic approaches. Twenty protein spots were found to have over expressed in resistant isolates and were identified. Among these Rv3208A, Rv2623, Rv1360, Rv2140c, Rv1636, and Rv2185c are six proteins with unknown functions or undefined role. Docking results showed that AK and KM binds to the conserved domain (DUF, USP-A, Luciferase, PEBP and Polyketidecyclase/dehydrase domain) of these hypothetical proteins and over expression of these proteins might neutralize/modulate the effect of drug molecules. TBPred and GPS-PUP predicted cytoplasmic nature and potential pupylation sites within these identified proteins, respectively. String analysis also suggested that over expressed proteins along with their interactive partners might be involved in aminoglycosides resistance. Cumulative effect of these over expressed proteins could be involved in AK and KM resistance by mitigating the toxicity, repression of drug target and neutralizing affect. These findings need further exploitation for the expansion of newer therapeutics or diagnostic markers against AK and KM resistance so that an extreme condition like XDR-TB can be prevented. Frontiers Media S.A. 2016-11-15 /pmc/articles/PMC5108770/ /pubmed/27895634 http://dx.doi.org/10.3389/fmicb.2016.01816 Text en Copyright © 2016 Sharma, Lata, Singh, Deo, Venkatesan and Bisht. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Sharma, Divakar Lata, Manju Singh, Rananjay Deo, Nirmala Venkatesan, Krishnamurthy Bisht, Deepa Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title | Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title_full | Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title_fullStr | Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title_full_unstemmed | Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title_short | Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS |
title_sort | cytosolic proteome profiling of aminoglycosides resistant mycobacterium tuberculosis clinical isolates using maldi-tof/ms |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108770/ https://www.ncbi.nlm.nih.gov/pubmed/27895634 http://dx.doi.org/10.3389/fmicb.2016.01816 |
work_keys_str_mv | AT sharmadivakar cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms AT latamanju cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms AT singhrananjay cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms AT deonirmala cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms AT venkatesankrishnamurthy cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms AT bishtdeepa cytosolicproteomeprofilingofaminoglycosidesresistantmycobacteriumtuberculosisclinicalisolatesusingmalditofms |